Randomized Clinical Trial to Compare the Treatment of Mild Acute Diverticulitis With or Without Antibiotics
NCT02785549 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 480
Last updated 2020-05-14
Summary
Patients with mild acute diverticulitis (modified Neff 0 grade), following the inclusion criteria and giving informed consent, will be included in the study protocol and will be randomly assigned to one of the treatment arms: symptomatic treatment with NSAID plus antibiotic vs symptomatic treatment with NSAID only. They will be followed-up at 48 hours, 7 days, 30 days and 3 months from the onset of the episode.
Conditions
- Acute Diverticulitis
Interventions
- DRUG
-
600 mg/8hours
- DRUG
-
1 g/8 hours
- DRUG
-
Amoxicillin/clavulanic acid
875mg/125mg/8 hours
Sponsors & Collaborators
-
Corporacion Parc Tauli
lead OTHER
Principal Investigators
-
Neus Ruiz, MD · Corporacion Parc Tauli
-
Laura Mora, MD PhD · Corporacion Parc Tauli
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-30
- Primary Completion
- 2020-01-12
- Completion
- 2020-04-01
Countries
- Spain
Study Locations
More Related Trials
-
12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
NCT02107196 ·Status: COMPLETED ·Phase: PHASE3
-
Investigation of Efficacy and Safety of PPC-5650 to Experimental Induced Sensation and Pain in the Rectosigmoid
NCT01449487 ·Status: COMPLETED ·Phase: PHASE1
-
Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D)
NCT01303224 ·Status: COMPLETED ·Phase: PHASE2
-
Traditional Dietary Advice Vs. Mediterranean Diet in IBS
NCT05985018 ·Status: COMPLETED ·Phase: NA
-
Multicenter Withdrawal Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment
NCT01893606 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
NCT01896583 ·Status: COMPLETED ·Phase: PHASE2
-
Irritable Bowel Syndrome (IBS) Treatment With H1-receptor Antagonists
NCT01144832 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome
NCT00583128 ·Status: COMPLETED ·Phase: PHASE2
-
Peripheral Histamine 1 Receptor Blockade in IBS: Multicenter Trial
NCT01908465 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Rifaximin With NAC in IBS-D
NCT04557215 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
ConfocAl endomicroSCopy bAsed Diet Trial in IBS
NCT05097872 ·Status: RECRUITING ·Phase: NA
-
A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS.
NCT00139672 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)
NCT01923428 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)
NCT01553591 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)
NCT04129619 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of a Probiotic on Diverticular Symptoms
NCT02115867 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial to Evaluate the Effect of a Probiotic Mixture on Signs and Symptoms of Irritable Bowel Syndrome
NCT05565612 ·Status: COMPLETED ·Phase: NA
-
12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
NCT02320318 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of RDX5791 for the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS-C)
NCT01340053 ·Status: COMPLETED ·Phase: PHASE2
-
Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)
NCT04043455 ·Status: TERMINATED ·Phase: PHASE2
-
Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide
NCT00584298 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Dietary Fibre in Irritable Bowel Syndrome (IBS)
NCT03803319 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D)
NCT05509725 ·Status: RECRUITING ·Phase: PHASE4
-
A 14-week Pilot Prospective Clinical Trial With BiOkuris Product in Patients With Irritable Bowel Syndrome
NCT05780749 ·Status: COMPLETED ·Phase: NA
-
A Trial for New Treatment of Adult Participants With Irritable Bowel Syndrome
NCT03721107 ·Status: COMPLETED ·Phase: PHASE2